A randomized controlled trial (volunteer study) of sitafloxacin, enoxacin, levofloxacin and sparfloxacin phototoxicity

British Journal of Dermatology

Volumn 149, Issue 6, 2003, Pages 1232-1241

  Dawe, R S ^a   Ibbotson, S H ^a   Sanderson, J B ^a   Thomson, E M ^a   Ferguson, J ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

Enoxacin; Fluoroquinolone; Phototoxicity; Sitafloxacin; Sparfloxacin

Indexed keywords

ANTIINFECTIVE AGENT; CIPROFLOXACIN; CLINAFLOXACIN; DU 6859 A; ENOXACIN; LEVOFLOXACIN; LOMEFLOXACIN; MOXIFLOXACIN; OFLOXACIN; PLACEBO; QUINOLINE DERIVED ANTIINFECTIVE AGENT; QUINOLONE DERIVATIVE; SITAFLOXACIN; SPARFLOXACIN;

ADULT; ARTICLE; ASIA; ASIAN; CAUCASIAN; CHINA; CLINICAL TRIAL; COMPARATIVE STUDY; CONTACT DERMATITIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG ADMINISTRATION; DRUG BLOOD LEVEL; DRUG EFFECT; DRUG SENSITIVITY; ERYTHEMA; ETHNOLOGY; FEMALE; FOLLOW UP; HUMAN; JAPAN; LIGHT; MALE; NONPARAMETRIC TEST; NORMAL HUMAN; PHOTOTHERAPY; PHOTOTOXICITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RETINA PIGMENT DEGENERATION; SINGLE BLIND PROCEDURE; SKIN DEFECT; SKIN TEST; SPECTRAL SENSITIVITY; SUN EXPOSURE; UNITED KINGDOM; VOLUNTEER;

ADULT; ANTI-BACTERIAL AGENTS; ASIAN CONTINENTAL ANCESTRY GROUP; CHINA; DERMATITIS, PHOTOTOXIC; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; ENOXACIN; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; FLUOROQUINOLONES; FOLLOW-UP STUDIES; HUMANS; JAPAN; LIGHT; MALE; MIDDLE AGED; OFLOXACIN; SCOTLAND; SINGLE-BLIND METHOD; SKIN TESTS; STATISTICS, NONPARAMETRIC;

EID: 0346095245     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2003.05582.x     Document Type: Article

References (32)

1. Johnson BE, Ferguson J. Drug and chemical photosensitivity. Semin Dermatol 1990; 9: 39-46.
2. Zelickson AS. Phototoxic reactions with nalidixic acid. JAMA 1964; 190: 556-7.
3. Birkett DA, Garretts M, Stevenson CJ. Phototoxic bullous eruptions due to nalidixic acid. Br J Dermatol 1969; 81: 342-4.
4. Le Cleach L, Chosidow O, Peytavin G et al. Blue-black pigmentation of the legs associated with pefloxacin therapy. Arch Dermatol 1995; 131: 856-66.
5. Vousden M, Ferguson J, Richards J et al. Evaluation of phototoxic potential of gemifloxacin in healthy volunteers compared with ciprofloxacin. Chemotherapy 1999; 45: 512-20.
6. Man I, Murphy J, Ferguson J. Fluoroquinolone phototoxicity: a comparison of moxifloxacin and lomefloxacin in normal volunteers. J Antimicrobial Chemother 1999; 43 (Suppl. B): 77-82.
7. Ferguson J, McEwen J, Al-Ajmi H et al. A comparison of the photosensitizing potential of trovafloxacin with that of other quinolones in healthy subjects. J Antimicrobial Chemother 2000; 45: 503-9.
8. Traynor NJ, Barratt MD, Lovell WW et al. Comparison of an in vitro cellular phototoxicity model against controlled clinical trials of fluoroquinolone skin phototoxicity. Toxicology In Vitro 2000; 14: 275-83.
9. Ferguson J, Johnson BE. Ciprofloxacin-induced photosensitivity: in vitro and in vivo studies. Br J Dermatol 1990; 123: 9-20.
10. Ferguson J, Johnson BE. Clinical and laboratory studies of the photosensitizing potential of norfloxacin, a 4-quinolone broad-spectrum antibiotic. Br J Dermatol 1993; 128: 285-9.
11. Lopitaux R, Hermet R, Sirot J et al. Tolerance de la perfloxacine au-cours du traitement d'une serie d'infections osteo-articulaires. Therapie 1985; 40: 349-52.
12. Bowie WR, Willetts V, Jewesson PJ. Adverse reactions in a dose-ranging study with a new long-acting fluoroquinolone, fleroxacin. Antimicrobial Agents Chemother 1989; 33: 1778-82.
13. Kuramaji Y, Shono M. Scarified photopatch testing in lomefloxacin photosensitivity. Contact Dermatitis 1992; 26: 5-10.
14. Food and Drug Administration. FDA Committee urges stronger warnings on maxaquin. Script 1993; 1810: 32-3 (Editorial).
15. Correia O, Delgado L. Bullous photodermatosis after lomefloxacin. Arch Dermatol 1994; 130: 808-9.
16. Cohen JB, Bergstresser PR. Inadvertent phototoxicity from home tanning equipment. Arch Dermatol 1994; 130: 804-6.
17. Reavy HJ, Traynor NJ, Gibbs NK. Photogenotoxicity of skin phototumorigenic fluoroquinolone antibiotics detected using the comet assay. Photochem Photobiol 1997; 66: 368-73.
18. Chetelat A-A. Albertini S, Gocke E. The photomutagenicity of fluoroquinolones in tests for gene mutation, chromosomal aberration, gene conversion and DNA breakage (comet assay). Mutagenesis 1996; 11: 497-504.
19. Johnson BE, Gibbs NK, Ferguson J. Quinolone antibiotic with potential to photosensitize skin tumorigenesis. J Photochem Photobiol B 1997; 37: 171-3.
20. Klecak F, Urbach F, Urwyler H. Fluoroquinolone antibacterials enhance UVA-induced skin tumours. J Photochem Photobiol B 1997; 37: 174-81.
21. Shimoda K, Yoshida M, Wagai N et al. Phototoxic lesions induced by quinolone antibacterial agents in auricular skin and retina of albino mice. Toxicol Pathol 1993; 21: 554-61.
22. Rosen ES. Filtration of non-ionising radiation by the ocular media. In: Hazards of Light (Cronley-Dillon J, Rosen ES. Marshall J. eds). Oxford: Pergamon Press. 1986: 145-52.
23. Izu R, Gardearabal J, Gonzalez M et al. Enoxacin-induced photosensitivity: study of two cases. Photoderm Photoimmunol Photomed 1992; 9: 86-8.
24. Kang JS, Kim TH, Park KB et al. Enoxacin photosensitivity. Photodermatol Photoimmunol Photomed 1993; 9: 159-61.
25. Hamanaka H, Mizutani H, Shimizu M. Sparfloxacin-induced photosensitivity and the occurrence of a lichenoid tissue reaction after prolonged exposure. J Am Acad Dermatol 1998; 38: 945-9.
26. Pierfitte C, Royer RJ, Moore N, Bégaud B. The link between sunshine and phototoxicity of sparfloxacin. Br J Clin Pharmacol 2000; 49: 609-12.
27. Lipsky BA, Dorr MB, Magner DJ, Talbot GH. Safety profile of sparfloxacin in North American phase III clinical trials (Abstract no. LM-57). In: Program and Abstracts of the 36th Interscience Conference on Antimicrobial Agents and Chemotherapy (New Orleans) Washington, DC American Society for Microbiology, 1996 (Abstract).
28. Fitzpatrick TB, Eisen AZ, Wollt K et al. Dermatology in General Medicine. Vol. 1, 4th edn. New York: McGraw-Hill, 1993.
29. Ferguson J, Dawe R. Phototoxicity in quinolones: comparison of ciprofloxacin and grepafloxacin. J Antimicrobial Chemother 1997: 40 (Suppl. A): 93-8.
30. Ferguson J, McEwen J, Gohler K et al. Phototoxic potential of gatifloxacin, a new fluoroquinolone antimicrobial. Drugs 1999: 58 (SuppL): 397-9.
31. Marutani K, Matsumoto M, Otabe Y et al. Reduced phototoxicity of a fluoroquinolone antibacterial agent with a methoxy group at the 8 position in mice irradiated with long-wavelength UV light. Antimicrob Agents Chemother 1993; 37: 2217-23.
32. Bech-Thomsen N, Angelo HR, Wulf HC. Skin pigmentation as a predictor of minimal phototoxic dose after oral methoxsalen. Arch Dermatol 1994; 130: 464-8.